Author Information
Mark Anthony Fernance Kendall is an esteemed researcher affiliated with both the Delivery of Drugs and Genes Group (D(2)G(2)) at the Australian Institute for Bioengineering and Nanotechnology, University of Queensland, St. Lucia, QL 4072, Australia, and the Australian National University in Canberra, Australian Capital Territory 2600, Australia. His work focuses on the intersection of nanotechnology and biomedical engineering, particularly the development and application of microprojection arrays and microneedle technologies for drug and vaccine delivery.
Research Contributions
Mark Anthony Fernance Kendall has made significant contributions to the field of nanotechnology and biomedical engineering. His research primarily explores innovative methods for transdermal delivery of vaccines and drugs, using microprojection arrays and microneedles. Notable studies include the assessment of skin penetration depth and delivery efficiency of microprojection arrays, investigation of immune responses to vaccine delivery through microneedles, and the development of low-inflammatory patches targeting Langerhans cells. His work has demonstrated the potential for enhancing vaccine efficacy and creating non-invasive, efficient delivery methods.
Aliases
Mark Anthony Fernance Kendall is also known by several aliases, including M.a.f. Kendall, Ma Kendall, M. A. Kendall, Mark A. Kendall, Mark A F Kendall, M. Kendall, M. A. F. Kendall, Mark Anthony Fernance Kendall, Mark A Kendall, M. A.f. Kendall, M A F Kendall, Mark A. F. Kendall, Mark A.f. Kendall, and Mark Kendall.
Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
4268 |
| h-index |
38 |
| Paper Count |
174 |
